IR
58
3
WDC
70
2
PRU
62
2
AMAT
52
3
A
43
-5
FFIV
47
-3
AVGO
54
12
SWKS
55
2
STI
18
11
NI
65
-2
GS
76
6
DGX
35
2
NDAQ
74
4
FSLR
73
15
AME
72
6
EXPD
51
16
ADM
47
2
WYNN
50
2
LRCX
62
6
UHS
55
3
IR
58
3
WDC
70
2
PRU
62
2
AMAT
52
3
A
43
-5
FFIV
47
-3
AVGO
54
12
SWKS
55
2
STI
18
11
NI
65
-2
GS
76
6
DGX
35
2
NDAQ
74
4
FSLR
73
15
AME
72
6
EXPD
51
16
ADM
47
2
WYNN
50
2
LRCX
62
6
UHS
55
3
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
64

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.01
Seasonality Move:
0.94%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
64
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.01. The Score for JQC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.01
    The current trend is relatively stagnant and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.25 Sell
Chaikin Money Flow: 823768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.99 - 5.07) Sell
Bollinger Bands (100): (5.05 - 5.45) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.02 Sell
20-day SMA: 5.05 Sell
50-day SMA: 5.07 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.02 Sell
20-day EMA: 5.04 Sell
50-day EMA: 5.1 Sell
200-day EMA: 5.29 Sell

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):